Debate: Challenges and solutions for new treatment options in mUC

Share :
Published: 9 Nov 2024
Views: 1577
Rating:
Save
Dr. María José Juan Fita, Dr. Bernadett Szabados, Prof. Rafael S. Grajewski, Dr. Diego Teyssonneau

Interactive industry seminar from EMUC 2024 in Lisbon, featuring:

  • Welcome and introduction, Chair - Dr. María José Juan Fita
  • Guidelines update: Emerging treatments in the landscape of 1st line mUC - Dr. Bernadett Szabados
  • Optimising patient selection: Choosing the right patient profile for new therapies in 2nd line mUC - Dr. Diego Teyssonneau
  • Managing ocular toxicities with new therapeutic options: Key considerations - Prof. Rafael S. Grajewski
  • Q&A and closing - Whole panel

This industry symposium is funded and organised by Johnson & Johnson in EMEA and is intended for healthcare professionals only.

Supported by an independent educational grant from Johnson & Johnson